New naphthoquinones and an alkaloid with in vitro activity against Toxoplasma gondii RH and EGS strains

Experimental Parasitology

Volumn 132, Issue 4, 2012, Pages 450-457

  Ferreira, Ronize Andréia ^a,b   de Oliveira, Alaide Braga ^b   Gualberto, Simone Andrade ^c   Miguel Del Corral, José M ^d   Fujiwara, Ricardo Toshio ^b   Gazzinelli Guimarães, Pedro Henrique ^b   de Almeida Vitor, Ricardo Wagner ^b  

^a Dentistry   (Brazil)

^b FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^c UNIVERSIDADE ESTADUAL DO SUDOESTE DA BAHIA   (Brazil)

^d UNIVERSITY OF SALAMANCA   (Spain)

Author keywords

In vitro activity; Liriodenine; Naphthoquinones; Toxoplasma gondii

Indexed keywords

ANTIMALARIAL AGENT; APORPHINE DERIVATIVE; ATOVAQUONE; COCCIDIOSTATIC AGENT; LIRIODENINE; NAPHTHOQUINONE; SULFADIAZINE;

ANIMAL; ARTICLE; CELL CULTURE; CHEMISTRY; CYTOLOGY; DRUG EFFECT; FEMALE; FIBROBLAST; HUMAN; IC 50; MALE; MOUSE; PARASITOLOGY; PATHOGENICITY; PREPUCE; STRUCTURE ACTIVITY RELATION; TOXOPLASMA; TOXOPLASMOSIS;

ANIMALS; ANTIMALARIALS; APORPHINES; ATOVAQUONE; CELLS, CULTURED; COCCIDIOSTATS; FEMALE; FIBROBLASTS; FORESKIN; HUMANS; INHIBITORY CONCENTRATION 50; MALE; MICE; NAPHTHOQUINONES; STRUCTURE-ACTIVITY RELATIONSHIP; SULFADIAZINE; TOXOPLASMA; TOXOPLASMOSIS, ANIMAL;

MLCS; MLOWN;

EID: 84872816791     PISSN: 00144894     EISSN: 10902449     Source Type: Journal    
DOI: 10.1016/j.exppara.2012.09.003     Document Type: Article

References (45)

1. Araújo, F.G., Huskinson, J., Remington, J.S., Remarkable in vitro and in vivo activities of hydroxynaphthoquinone 566C80 against tachyzoites and cysts of Toxoplasma gondii. Antimicrob. Agents Chemother. 35 (1991), 293–299.
2. Bittner, S., Lempert, D., Reaction of hydroxylamines with 1,4-quinones: a new direct synthesis of aminoquinones. Synthesis 9 (1994), 917–919.
3. Bittner, S., Meenakshi, C., Temtsin, G., N,N-bis (quinonyl) amines; synthesis and X-ray structure. Tetrahedron 57 (2001), 7423–7429.
4. Bittencourt, L.H., Lopes-Mori, F.M., Mitsuka-Breganó, R., Valentim-Zabott, M., Freire, R.L., Pinto, S.B., Navarro, I.T., Seroepidemiology of toxoplasmosis in pregnant women since the implementation of the surveillance program of toxoplasmosis acquired in pregnancy and congenital in the western region of Paraná, Brazil. Rev. Bras. Ginecol. Obstet. 2 (2012), 63–68.
5. Camacho, M.R., Kirby, G.C., Warhurst, D.C., Croft, S.L., Phillipson, J.D., Oxoaporphine alkaloids and quinones from Stephania dinklagei and evaluation of their antiprotozoal activities. Planta Med. 66 (2000), 478–480.
6. Chang, H.C., Chang, F.R., Wu, Y.C., Lay, Y.H., Anti-cancer effect of liriodenine on human lung cancer cells. Kaohsiung J. Med. Sci. 20 (2004), 365–371.
7. Costa, E.V., Pinheiro, M.L., De Souza, A.D., Barison, A., Campos, F.R., Valdez, R.H., Ueda-Nakamura, T., Filho, B.P., Nakamura, C.V., Trypanocidal activity of oxoaporphine and pyrimidine-β-carboline alkaloids from the branches of Annona foetida Mart. (Annonaceae). Molecules 16 (2011), 9714–9720.
8. Couladouros, E.A., Plyta, Z.F., Haroutounian, S.A., Efficient Synthesis of aminonaphthoquinones and azidobenzohydroquinones: mechanistic considerations of the reaction of hydrazoic acid with quinones. An Overview. J. Org. Chem. 62 (1997), 6–10.
9. Couzinet, S., Dubremetz, J.F., Buzoni-Gatel, D., Jeminet, G., Prensier, G., In vitro activity of the polyether ionophorous antibiotic monensin against the cyst form of Toxoplasma gondii. Parasitology 121 (2000), 359–365.
10. De la Cruz Chacón, L., Gonzáles-Esqquinca, A.R., Liriodenine alkaloid in Annona diversifolia during early development. Nat. Prod. Res. 26 (2012), 42–49.
11. Do Campo, R., Cuz, F.S., Boveris, A., Muniz, R.P.A., Esquivel, D.M.S., Lipid peroxidation and the generation of free radicals, superoxide anion and hydrogen peroxide in – lapachone treated Trypanosoma cruzi epimastigotes. Arch. Biochem. Biophys. 186 (1978), 292–297.
12. Edstrom, E.D., Jones, Z., Regioselective oxidative amination of 3-carbomethoxyindole-4,7-quinones. Tetrahedron Lett. 36 (1995), 7039–7042.
13. Elsaid, M.M.A., Vitor, R.W.A., Frézard, F.J.G., Martins, M.S., Protection against toxoplasmosis in mice immunized with different antigens of Toxoplasma gondii incorporated into liposomes. Mem. Inst. Oswaldo Cruz 94 (1999), 485–490.
14. Ferreira, A.M., Vitor, R.W.A., Gazzinelli, R.T., Melo, M.N., Genetic analysis of natural recombinant Brazilian Toxoplasma gondii strains by mulyilocus PCR–RFLP. Infect. Genet. Evol. 6 (2006), 22–31.
15. Ferreira, R.A., Oliveira, A.B., Ribeiro, M.F., Tafuri, W.L., Vitor, R.W., Toxoplasma gondii: in vitro and in vivo activities of the hydroxynaphthoquinone 2-hydroxy-3-(1′-propen-3-phenyl)-1,4-naphthoquinone alone or combined with sulfadiazine. Exp. Parasitol. 113 (2006), 125–129.
16. Francisco, F.M., Souza, S.L.P., Gennari, S.M., Pinheiro, S.R., Muradian, V., Soares, R.M., Seroprevalence of toxoplasmosis in a low-income community in the São Paulo municipality, SP, Brazil. Rev. Inst. Med. Trop. Sao Paulo 48 (2006), 167–170.
17. Hansen, J., Bross, P., A cellular viability assay to monitor drug toxicity. Methods Mol. Biol. 648 (2010), 303–311.
18. Hoet, S., Steviigny, C., Block, S., Opperdoes, F., Colson, P., Baldeyrou, B., Lansiaux, A., Bailly, C., Quetin-Leclercq, J., Alkaloids from Cassytha filiformis and related aporphines: antitrypanosomal activity, cytotoxicity, and interaction with DNA and topoisomerases. Planta Med. 70 (2004), 407–413.
19. Hsieh, T.J., Liu, T.Z., Chern, C.L., Tsao, D.A., Lu, F.J., Syu, Y.H., Hsieh, P., Hu, H.S., Chang, T.T., Chen, C.H., Liriodenine inhibits the proliferation of human hepatoma cell lines by blocking cell cycle progression and nitric oxide-mediated activation activation of p53 expression. Food Chem. Toxicol. 43 (2005), 1117–1126.
20. Hudson, A.T., Randall, A.W., Ginger, C.D., Hill, B., Latter, V.S., McHardy, N., Williams, R.B., Novel antimalarial hidroxynaphthoquinnes with potent broad spectrum antiprotozoal activity. Parasitology 90 (1985), 45–55.
21. Huskinson-Mark, J., Araújo, F.G., Remington, J.S., Evaluation of the effect of drugs on the cyst form of Toxoplasma gondii. J. Infect. Dis. 164 (1991), 170–177.
22. Kovacs, J.A., Efficacy of atovaquone in treatment of toxoplasmosis in patients with AIDS. The Lancet 340 (1992), 637–638.
23. Kumar, M.R., Aithal, K., Rao, B.N., Udupa, N., Rao, B.S., Cytotoxic, genotoxic and oxidative stress induced by 1,4-naphthoquinone in B16F1 melanoma tumor cells. Toxicol. In Vitro 23 (2009), 242–250.
24. Lozano-Contreras, G., Magnoliaceae nativas del Brasil. Rev. Acad. Colombiana de Ciênc. 57 (1990), 579–583.
25. McCabe, R.E., Oster, S., Current recommendations and future prospects in the treatment of toxoplasmosis. Drugs 38 (1989), 973–987.
26. Meneceur, P., Bouldouyre, M., Aubert, D., Villena, I., Menotti, J., Sauvage, V., Garin, J., Derouin, F., In vitro susceptibility of various genotypic strains of Toxoplasma gondii to pyrimethamine sulfadiazine and atovaquone. J. Antimicrob. Chemother. 52 (2008), 1269–1277.
27. Miguel Del Corral, J.M., Castro, M.A., Gordaliza, M., Martín, M.L., Gualberto, S.A., Gamito, A.M., Cuevas, C., San feliciano, A., Synthesis and cytotoxicity of new aminoterpenylquinones. Bioorg. Med. Chem. 13 (2005), 631–644.
28. Min, X., Andrews, K.T., Birrell, G.W., Tran, T.L., Camp, D., Davis, R.A., Quinn, R.J., Quinn, R.J., Psammaplysin H, a new antimalarial bromotyrosine alkaloid from a marine sponge of the genus Pseudoceratina. Bioorg. Med. Chemother. Lett. 21 (2011), 846–848.
29. Mollataghi, A., Coudiere, E., Hadi, A.H., Mukhtar, M.R., Awang, K., Litaudon, M., Ata, A., Anti-acetylcholinesterase, anti-α-glucosidase, anti-leishmanial and anti-fungal activities of chemical constituents of Beilschmiedia species. Fitoterapia 83 (2012), 298–302.
30. Osunkalu, V.O., Akanmu, S.A., Nkolika, J.O., Igwebuike, I.V., Adewumi, A.A., Akinde, R.O., Onwuezobe, I.A., Seroprevalence of Toxoplasma gondii IgG antibody in HIV-infected patients at the Lagos University Teaching Hospital. HIV AIDS (Auckl) 3 (2011), 101–105.
31. Rodriguez, J.B., Szajnman, S.H., New antibacterials for the treatment of toxoplasmosis; a patent review. Expert Opin. Ther. Pat. 3 (2012), 311–333.
32. Romand, S., Pudney, M., Deroin, F., In vitro and in vivo activities of hydroxynaphthoquinone atovaquone alone or combined with pyrimethamine, sulfadiazine, clarithromycin, or minocycline against Toxoplasma gondii. Antimicrob. Agents Chemother. 37 (1993), 2371–2378.
33. Sabin, A.B., Toxoplasmic encephalitis in children. J. Am. Med. Assoc. 116 (1941), 801–807.
34. Shubar, H.M., Lachenmaier, S., Heimesaat, M.M., Lohman, U., Mauludin, R., Mueller, R.H., Fitzner, R., Borner, K., Liesenfeld, O., SDS-coated atovaquone nanosuspensions show improved therapeutic efficacy against experimental acquired and reactivated toxoplasmosis by improving passage of gastrointestinal and blood-brain barriers. J. Drug Target. 19 (2011), 114–124.
35. Spalding, S.M., Amendoeira, M.R.R., Klein, C.H., Ribeiro, L.C., Serological screening and toxoplasmosis exposure factors among pregnant women in South of Brazil. Rev. Soc. Bras. Med. Trop. 38 (2005), 173–177.
36. Sroka, S., Bartelheimer, N., Winter, A., Heukelbach, J., Ariza, L., Ribeiro, H., Prevalence and risk factors of toxoplasmosis among pregnanat women in Fortaleza, Northeastern Brazil. Am. J. Trop. Med. Hyg. 83 (2010), 528–533.
37. Tenant-Flowers, M., Boyle, M.J., Carey, D., Marriot, D.J., HARKNESS, J.L., Peenny, R., Cooper, D.A., Sulfadiazine desensitization in patients with AIDS and cerebral toxoplasmosis. AIDS 5 (1991), 311–315.
38. Vidigal, P.V.T., Santos, D.V.V., Castro, F.C., Couto, J.C., Vitor, R.W.A., Brasileiro Filho, G., Prenatal toxoplasmosis diagnosis from amniotic fluid by PCR. Rev. Soc. Bras. Med. Trop. 35 (2002), 1–6.
39. Wallace, G.R., Stanford, M.R., Immunity and toxoplasma retinochoroiditis. Clin. Exp. Immunol. 153 (2008), 309–315.
40. Wang, W., Gallant, J.N., Katz, S.I., Dolloff, N.G., Smith, C.D., Abdulghani, J., Allen, J.E., Dicker, D.T., Hong, B., Navaraj, A., El-Deiry, W.S., Quinacrine sensitizes hepatocellular carcinoma cells to TRAIL and chemotherapeutic agents. Cancer Biol. Ther. 12 (2011), 229–238.
41. Weller, I.V.D., Williams, I.G., ABC of AIDS: treatment of infectious. Br. Med. J. 322 (2001), 1350–1354.
42. Winterhalter, S., Severing, K., Stammen, J., Maier, A.K., Godehardt, E., Jousen, A.M., Does atovaquone prolong the disease-free interval of toxoplasmic retinochoroiditis?. Graefes Arch. Clin. Exp. Ophthalmol. 248 (2010), 1187–1192.
43. Wong, S.Y., Israelsky, D.M., Remington, J.S., AIDS associated toxoplasmosis. Sande, M.A., Volberding, P., (eds.), fourth ed. The Medical of AIDS, 1994, The W.B. Sounds Co., Philadelphia, 60–493.
44. Woo, S.H., Sun, N.J., Cassady, J.M., Snapka, R.M., Topoisomerase II inhibition by aporphine alkaloids. Biochem. Pharmacol. 57 (1999), 1141–1145.
45. Wright, C.W., Phillipson, J.D., Natural products and development of selective antiprotozoal drugs. Phytother. Res. 4 (1990), 127–139.